vs

Side-by-side financial comparison of TreeHouse Foods, Inc. (THS) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $840.3M, roughly 1.1× TreeHouse Foods, Inc.). DENTSPLY SIRONA Inc. runs the higher net margin — -15.2% vs -31.6%, a 16.4% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs 0.1%). Over the past eight quarters, DENTSPLY SIRONA Inc.'s revenue compounded faster (0.4% CAGR vs -3.9%).

TreeHouse Foods Inc. is a multinational food processing company specializing in producing private label packaged foods headquartered in Oak Brook, Illinois. Created in 2005 and consisting entirely of acquisitions, in 2010 the company had sales of $2 billion and employed over 4,000 people at 20 facilities. Food Processing magazine named TreeHouse Foods their 2010 Processor of the Year, calling them "the biggest company you never heard of". In 2015, the company was the 37th-largest food and bev...

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

THS vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.1× larger
XRAY
$961.0M
$840.3M
THS
Growing faster (revenue YoY)
XRAY
XRAY
+6.0% gap
XRAY
6.2%
0.1%
THS
Higher net margin
XRAY
XRAY
16.4% more per $
XRAY
-15.2%
-31.6%
THS
Faster 2-yr revenue CAGR
XRAY
XRAY
Annualised
XRAY
0.4%
-3.9%
THS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
THS
THS
XRAY
XRAY
Revenue
$840.3M
$961.0M
Net Profit
$-265.8M
$-146.0M
Gross Margin
18.8%
46.1%
Operating Margin
-30.2%
-14.5%
Net Margin
-31.6%
-15.2%
Revenue YoY
0.1%
6.2%
Net Profit YoY
-7717.6%
66.0%
EPS (diluted)
$-5.26
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
THS
THS
XRAY
XRAY
Q4 25
$961.0M
Q3 25
$840.3M
$904.0M
Q2 25
$798.0M
$936.0M
Q1 25
$792.0M
$879.0M
Q4 24
$905.7M
$905.0M
Q3 24
$839.1M
$951.0M
Q2 24
$788.5M
$984.0M
Q1 24
$820.7M
$953.0M
Net Profit
THS
THS
XRAY
XRAY
Q4 25
$-146.0M
Q3 25
$-265.8M
$-427.0M
Q2 25
$-2.9M
$-45.0M
Q1 25
$-31.8M
$20.0M
Q4 24
$58.7M
$-430.0M
Q3 24
$-3.4M
$-494.0M
Q2 24
$-16.7M
$-4.0M
Q1 24
$-11.7M
$18.0M
Gross Margin
THS
THS
XRAY
XRAY
Q4 25
46.1%
Q3 25
18.8%
48.8%
Q2 25
17.4%
52.4%
Q1 25
14.5%
53.0%
Q4 24
19.5%
49.3%
Q3 24
15.6%
52.1%
Q2 24
16.3%
51.9%
Q1 24
13.6%
53.1%
Operating Margin
THS
THS
XRAY
XRAY
Q4 25
-14.5%
Q3 25
-30.2%
-24.1%
Q2 25
3.4%
-13.7%
Q1 25
-0.7%
7.2%
Q4 24
8.9%
-56.2%
Q3 24
3.8%
-48.6%
Q2 24
-0.5%
5.1%
Q1 24
-0.6%
4.4%
Net Margin
THS
THS
XRAY
XRAY
Q4 25
-15.2%
Q3 25
-31.6%
-47.2%
Q2 25
-0.4%
-4.8%
Q1 25
-4.0%
2.3%
Q4 24
6.5%
-47.5%
Q3 24
-0.4%
-51.9%
Q2 24
-2.1%
-0.4%
Q1 24
-1.4%
1.9%
EPS (diluted)
THS
THS
XRAY
XRAY
Q4 25
$-0.74
Q3 25
$-5.26
$-2.14
Q2 25
$-0.06
$-0.22
Q1 25
$-0.63
$0.10
Q4 24
$1.12
$-2.09
Q3 24
$-0.07
$-2.46
Q2 24
$-0.32
$-0.02
Q1 24
$-0.22
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
THS
THS
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$21.0M
$326.0M
Total DebtLower is stronger
$1.5B
$2.3B
Stockholders' EquityBook value
$1.3B
$1.3B
Total Assets
$3.8B
$5.4B
Debt / EquityLower = less leverage
1.18×
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
THS
THS
XRAY
XRAY
Q4 25
$326.0M
Q3 25
$21.0M
$363.0M
Q2 25
$17.1M
$359.0M
Q1 25
$16.4M
$398.0M
Q4 24
$289.6M
$272.0M
Q3 24
$102.0M
$296.0M
Q2 24
$105.8M
$279.0M
Q1 24
$191.8M
$291.0M
Total Debt
THS
THS
XRAY
XRAY
Q4 25
$2.3B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$1.4B
Q4 24
$1.4B
$1.7B
Q3 24
$1.4B
Q2 24
$1.4B
Q1 24
$1.4B
Stockholders' Equity
THS
THS
XRAY
XRAY
Q4 25
$1.3B
Q3 25
$1.3B
$1.5B
Q2 25
$1.5B
$2.0B
Q1 25
$1.5B
$2.0B
Q4 24
$1.5B
$1.9B
Q3 24
$1.6B
$2.5B
Q2 24
$1.6B
$3.1B
Q1 24
$1.6B
$3.3B
Total Assets
THS
THS
XRAY
XRAY
Q4 25
$5.4B
Q3 25
$3.8B
$5.7B
Q2 25
$4.0B
$6.1B
Q1 25
$3.9B
$6.0B
Q4 24
$4.0B
$5.8B
Q3 24
$4.0B
$6.6B
Q2 24
$3.9B
$6.9B
Q1 24
$4.0B
$7.1B
Debt / Equity
THS
THS
XRAY
XRAY
Q4 25
1.70×
Q3 25
1.18×
Q2 25
0.98×
Q1 25
0.93×
Q4 24
0.90×
0.90×
Q3 24
0.90×
Q2 24
0.90×
Q1 24
0.87×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
THS
THS
XRAY
XRAY
Operating Cash FlowLast quarter
$38.2M
$101.0M
Free Cash FlowOCF − Capex
$60.0M
FCF MarginFCF / Revenue
6.2%
Capex IntensityCapex / Revenue
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
THS
THS
XRAY
XRAY
Q4 25
$101.0M
Q3 25
$38.2M
$79.0M
Q2 25
$-47.2M
$48.0M
Q1 25
$-53.5M
$7.0M
Q4 24
$296.2M
$87.0M
Q3 24
$41.4M
$141.0M
Q2 24
$-19.4M
$208.0M
Q1 24
$-52.4M
$25.0M
Free Cash Flow
THS
THS
XRAY
XRAY
Q4 25
$60.0M
Q3 25
$40.0M
Q2 25
$16.0M
Q1 25
$-12.0M
Q4 24
$36.0M
Q3 24
$98.0M
Q2 24
$-42.2M
$156.0M
Q1 24
$-80.7M
$-9.0M
FCF Margin
THS
THS
XRAY
XRAY
Q4 25
6.2%
Q3 25
4.4%
Q2 25
1.7%
Q1 25
-1.4%
Q4 24
4.0%
Q3 24
10.3%
Q2 24
-5.4%
15.9%
Q1 24
-9.8%
-0.9%
Capex Intensity
THS
THS
XRAY
XRAY
Q4 25
4.3%
Q3 25
4.3%
Q2 25
3.4%
Q1 25
2.2%
Q4 24
5.6%
Q3 24
4.5%
Q2 24
2.9%
5.3%
Q1 24
3.4%
3.6%
Cash Conversion
THS
THS
XRAY
XRAY
Q4 25
Q3 25
Q2 25
Q1 25
0.35×
Q4 24
5.05×
Q3 24
Q2 24
Q1 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

THS
THS

Retail Grocery Customers$670.6M80%
Food Away From Home And Other$85.3M10%
Co Manufacturing$84.4M10%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons